For decades, scientists have observed a curious phenomenon: people living at high altitudes appear to have lower rates of diabetes and better glucose control. From residents of the Andes Mountains to high-altitude wildlife, studies across different populations and species have consistently suggested that increasing altitude is associated with improved blood glucose regulation. However, the underlying biological mechanism has remained unclear. A recent study published in Cell Metabolism provides a compelling explanation. The research shows that chronic hypoxia triggers a remarkable metabolic adaptation in red blood cells, significantly increasing their glucose uptake and metabolic activity. Under low-oxygen conditions, red blood cell numbers rise and the abundance of glucose transporters such as GLUT1 increases, enabling these cells to consume more glucose and accelerate glycolysis. The glucose is then converted into 2,3-diphosphoglycerate (2,3-DPG), which enhances oxygen delivery to tissues. These findings suggest that red blood cells function as a major systemic glucose sink during hypoxia and may represent a promising therapeutic target for metabolic diseases such as diabetes.
A Curious Observation: Higher Altitude, Lower Diabetes Risk
Have you ever noticed an intriguing phenomenon? People who live at high altitudes for long periods seem to develop diabetes less frequently.
Interestingly, this observation is not merely anecdotal. From residents of the Andes Mountains to wild animals living on high plateaus, research across different populations and species points to a thought-provoking conclusion: the higher the altitude, the better the blood glucose control.
Could it be that the thin air at high altitudes hides some kind of natural “glucose-lowering code”?
This question has puzzled scientists for many years. In the past, the phenomenon was often attributed to the unique dietary patterns of high-altitude populations, greater physical activity, or complex environmental adaptations. However, these explanations never seemed entirely satisfactory. After all, when a physiological phenomenon occurs consistently across multiple species, it often reflects a more fundamental and evolutionarily conserved biological mechanism.
Recently, a new study published in the leading journal Cell Metabolism finally revealed the answer. The truth is surprising: the mysterious “glucose-lowering hero” has been quietly present in our bodies all along, in enormous numbers but largely overlooked — red blood cells.
A Century of Evidence Linking Hypoxia and Blood Glucose
The phenomenon of improved blood glucose regulation at high altitude can be traced back to the Harvard Fatigue Laboratory experiments in the 1920s. At that time, researchers brought healthy volunteers to the Chilean Andes at altitudes as high as 6,000 meters. They found that all participants showed significantly improved glucose tolerance.
Over the following century, this observation was repeatedly confirmed. Animal experiments also demonstrated that when mice are placed in hypoxic environments, their blood glucose levels drop significantly, and the improvement can persist for several weeks.
However, high-altitude environments involve multiple simultaneous changes, including low temperature, low humidity, and strong radiation. Determining which factor is primarily responsible for the glucose-lowering effect remained unresolved.
Even more puzzling, the improvement in blood glucose appeared to be independent of insulin. In hypoxic mice, insulin levels were actually lower than in normal mice, yet blood glucose declined more rapidly.
Step by Step: Identifying Red Blood Cells as the Key
To solve this mystery, the research team designed a series of carefully controlled experiments.
Step 1: Confirming Hypoxia as the Key Factor
The researchers placed mice in a simulated high-altitude hypoxic environment equivalent to more than 5,000 meters (8% oxygen). They also established a normal-oxygen control group and a pair-fed group that received the same amount of food as the hypoxia group, to rule out the possibility that reduced food intake caused lower blood glucose.
The results showed that only the hypoxia group experienced a significant drop in blood glucose, demonstrating that hypoxia itself was the key factor.
Figure 1: Hypoxia improves glucose tolerance, but the effect cannot be fully explained by increased glucose uptake in visceral organs.
Step 2: Tracking Where the Glucose Goes
The researchers then injected mice with radiolabeled glucose (FDG) and used PET/CT imaging to trace where glucose traveled in the body.
Under normal circumstances, glucose should primarily be consumed by major organs such as the brain, muscles, and liver.
However, the results were surprising. Data analysis showed that these organs could account for less than 30% of the increased glucose uptake. Nearly 70% of the glucose seemed to “disappear,” suggesting that it was being consumed somewhere else.
Figure 2: Representative 18F-FDG PET/CT scans showing accumulation of 18F-FDG signals in tissues after three weeks of hypoxia.
Step 3: Identifying Red Blood Cells
The research team noticed that mice exposed to hypoxia had nearly double the number of red blood cells — a condition known as erythrocytosis. Since red blood cells lack mitochondria and rely exclusively on glucose metabolism for energy, the researchers proposed a bold hypothesis: red blood cells might be the mysterious “glucose sink.”
To test this hypothesis, they performed two reverse experiments.
-
Bloodletting experiment: Hypoxic mice underwent periodic blood removal to reduce red blood cell levels back to normal. As a result, blood glucose levels rose again and the glucose-lowering effect disappeared.
-
Blood transfusion experiment: Mice in normal oxygen conditions received transfusions of red blood cells (either from hypoxic mice or normal mice). In both cases, blood glucose levels dropped significantly.
Figure 3: Erythrocytosis is a necessary and sufficient mechanism explaining hypoxia-induced hypoglycemia.
Together, these experiments demonstrated a striking conclusion: the number of red blood cells directly influences blood glucose levels. The more red blood cells present, the lower the blood glucose level.
Red Blood Cells: Not Just Oxygen Carriers but Glucose Consumers
After identifying red blood cells as the key players, the researchers continued investigating and discovered three remarkable findings.
First, hypoxia not only increases the number of red blood cells but also enhances the glucose-consuming capacity of each individual cell. Using stable isotope-labeled glucose tracking, the researchers found that a single red blood cell in hypoxic mice absorbs glucose 2.5 times faster than in normal mice. This occurs because hypoxia significantly increases the abundance of glucose transport proteins — particularly GLUT1 and GLUT4 — on newly formed red blood cells.
Second, the glucose consumed by red blood cells is not wasted. Instead, it is rapidly converted into an important molecule called 2,3-diphosphoglycerate (2,3-DPG). This molecule helps hemoglobin release oxygen to tissues more efficiently, which is precisely what the body needs under hypoxic conditions. In other words, red blood cells consume glucose in order to improve oxygen delivery.
Figure 4: Increased glycolytic flux in hypoxic red blood cells promotes synthesis of the hemoglobin allosteric regulator 2,3-diphosphoglycerate (2,3-DPG).
Third, the body possesses a rapid response mechanism. In addition to long-term adaptations (producing more glucose-consuming red blood cells), there is also an emergency response. When oxygen levels drop, a key enzyme in red blood cells — GAPDH — is released from the cell membrane, rapidly activating the glycolysis pathway and accelerating both glucose consumption and 2,3-DPG production. This mechanism can be triggered within minutes, explaining why blood glucose can decline quickly under hypoxic conditions.
Therapeutic Potential: Mimicking Hypoxia
If hypoxia can lower blood glucose, could we simulate hypoxia as a treatment strategy for diabetes?
The research team tested two approaches.
Strategy 1: Direct transfusion. When red blood cells from hypoxic mice were transfused into mice with type 1 diabetes, blood glucose levels dropped significantly. This suggests that increasing red blood cell numbers alone may help improve hyperglycemia.
Strategy 2: Pharmacological hypoxia simulation. The team previously developed a small-molecule drug called HypoxyStat, which can “trick” hemoglobin into sensing a hypoxic environment. When mice with high-fat diet-induced type 2 diabetes were treated with this drug, their red blood cell counts increased, blood glucose returned to normal levels, and glucose tolerance improved significantly.
Figure 5: Orthogonal approaches inducing erythrocytosis improve STZ- and HFD-induced hyperglycemia.
These experiments suggest that targeting red blood cells may represent a completely new strategy for diabetes therapy. Whether through transfusion, stimulation of red blood cell production, or pharmacological simulation of hypoxia, these approaches may help control blood glucose levels.
Conclusion
In summary, this 2026 study significantly reshapes our understanding of blood glucose regulation. Hypoxic environments induce both erythrocytosis and metabolic reprogramming in red blood cells, transforming them into powerful glucose-consuming units. This mechanism likely explains why individuals living at high altitudes tend to have better blood glucose control.
These findings remind us that even the most ordinary cells in our bodies may possess extraordinary biological functions.